These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 21854367)
1. Recent developments in the clinical use of the levonorgestrel-releasing intrauterine system. Gemzell-Danielsson K; Inki P; Heikinheimo O Acta Obstet Gynecol Scand; 2011 Nov; 90(11):1177-88. PubMed ID: 21854367 [TBL] [Abstract][Full Text] [Related]
2. The Femilis LNG-IUS: contraceptive performance-an interim analysis. Wildemeersch D; Janssens D; Andrade A Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705 [TBL] [Abstract][Full Text] [Related]
3. Resources and procedures in the treatment of heavy menstrual bleeding with the levonorgestrel-releasing intrauterine system (LNG-IUS) or hysterectomy in Brazil. Bahamondes MV; de Lima Y; Teich V; Bahamondes L; Monteiro I Contraception; 2012 Sep; 86(3):244-50. PubMed ID: 22459236 [TBL] [Abstract][Full Text] [Related]
4. Ease of insertion, contraceptive efficacy and safety of new T-shaped levonorgestrel-releasing intrauterine systems. Wildemeersch D; Janssens D; Vrijens M; Weyers S Contraception; 2005 Jun; 71(6):465-9. PubMed ID: 15914138 [TBL] [Abstract][Full Text] [Related]
5. Levonorgestrel-releasing intrauterine system for treating menstrual disorders: a patient satisfaction questionnaire. Radesic B; Sharma A Aust N Z J Obstet Gynaecol; 2004 Jun; 44(3):247-51. PubMed ID: 15191451 [TBL] [Abstract][Full Text] [Related]
6. Experience with the levonorgestrel-releasing intrauterine system among HIV-infected women. Lehtovirta P; Paavonen J; Heikinheimo O Contraception; 2007 Jan; 75(1):37-9. PubMed ID: 17161122 [TBL] [Abstract][Full Text] [Related]
7. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives. Modesto W; Bahamondes MV; Bahamondes L Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309 [TBL] [Abstract][Full Text] [Related]
8. Use of the levonorgestrel-releasing intrauterine system in renal transplant recipients: a retrospective case review. Ramhendar T; Byrne P Contraception; 2012 Sep; 86(3):288-9. PubMed ID: 22305914 [TBL] [Abstract][Full Text] [Related]
9. Ease of insertion and clinical performance of the levonorgestrel-releasing intrauterine system in nulligravidas. Bahamondes MV; Hidalgo MM; Bahamondes L; Monteiro I Contraception; 2011 Nov; 84(5):e11-6. PubMed ID: 22018132 [TBL] [Abstract][Full Text] [Related]
10. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development. Shaamash AH; Sayed GH; Hussien MM; Shaaban MM Contraception; 2005 Nov; 72(5):346-51. PubMed ID: 16246660 [TBL] [Abstract][Full Text] [Related]
11. Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders. Lukes AS; Reardon B; Arepally G Fertil Steril; 2008 Sep; 90(3):673-7. PubMed ID: 18001734 [TBL] [Abstract][Full Text] [Related]
12. A multicentre, open-label, randomised phase III study comparing a new levonorgestrel intrauterine contraceptive system (LNG-IUS 8) with combined oral contraception in young women of reproductive age. Borgatta L; Buhling KJ; Rybowski S; Roth K; Rosen K Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):372-9. PubMed ID: 27494570 [TBL] [Abstract][Full Text] [Related]
13. The benefits and risks of using a levonorgestrel-releasing intrauterine system for contraception. Mansour D Contraception; 2012 Mar; 85(3):224-34. PubMed ID: 22067761 [TBL] [Abstract][Full Text] [Related]
14. Selection and performance of the levonorgestrel-releasing intrauterine system. Lähteenmäki P; Bardin CW; Elomaa K; Haukkamaa M; Kivijärvi A; Kuukankorpi A; Venhola M; Tuominen J Acta Obstet Gynecol Scand Suppl; 1997; 164():69-74. PubMed ID: 9225643 [TBL] [Abstract][Full Text] [Related]
15. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)]. Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443 [TBL] [Abstract][Full Text] [Related]
16. The levonorgestrel intrauterine system: the benefits of reduced bleeding. Cameron IT Eur J Contracept Reprod Health Care; 2001 Jan; 6 Suppl 1():27-32. PubMed ID: 11336431 [TBL] [Abstract][Full Text] [Related]
17. Randomised comparative trial of thermal balloon ablation and levonorgestrel intrauterine system in patients with idiopathic menorrhagia. Shaw RW; Symonds IM; Tamizian O; Chaplain J; Mukhopadhyay S Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):335-40. PubMed ID: 17627692 [TBL] [Abstract][Full Text] [Related]
18. A pilot study on the acceptability of levonorgestrel-releasing intrauterine device by young, single, nulliparous Chinese females following surgical abortion. Li CF; Lee SS; Pun TC Contraception; 2004 Mar; 69(3):247-50. PubMed ID: 14969674 [TBL] [Abstract][Full Text] [Related]
19. Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use. Rönnerdag M; Odlind V Acta Obstet Gynecol Scand; 1999 Sep; 78(8):716-21. PubMed ID: 10468065 [TBL] [Abstract][Full Text] [Related]
20. The levonorgestrel intrauterine system: cohort study to assess satisfaction in a postpartum population in Kenya. Hubacher D; Masaba R; Manduku CK; Chen M; Veena V Contraception; 2015 Apr; 91(4):295-300. PubMed ID: 25601351 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]